A recent clinical study at the cancer treatment center in Los Angeles reveals promising outcomes for recurrent prostate cancer using targeted PSMA nuclear therapy. This could revolutionize available treatment options.
A new study reveals that PSMA treatment can postpone the need for hormonal therapy in patients with early prostate cancer, offering new hope for improved treatment options. This breakthrough could significantly change the management of this cancer type.
Recent advancements in routine prostate cancer screenings allow doctors to utilize modern techniques for improved diagnostic accuracy. These developments empower men to make informed health decisions.
A recent British study reveals that hormonal patches, typically used to alleviate menopause symptoms in women, can effectively treat prostate cancer in men. Conducted by researchers at University College London, the study involved 1,360 men with advanced localized prostate cancer.
Fish oil, rich in omega-3 fatty acids, is considered a beneficial supplement for men suffering from prostatitis, aiding in inflammation reduction and overall health improvement.